November 10, 2025 · Form 4 insider transaction
Connaughton Bernadette sold 2,000 shares of Halozyme Therapeutics, Inc. at $68.48 per share, a transaction worth $137.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.